Pooja Saraiya

Pooja Saraiya

Director Director DIN 02604646
DIN 02604646 First appointment Jul 2009 Primary industry Life Sciences
Unlock full profile Investments · shareholding · contact details
Past companies 2 historical roles
Total affiliations 2 Since Jul 2009
Shareholding value •••• Premium profile

About Pooja Saraiya

Data last updated:

Pooja Saraiya was a Director at Krish Biotech Research Private Limited (2009–2014) and Director at Primerose Vinimay Private Limited (2009–2014). The companies operate in Life Sciences and Financial Services.

DIN 02604646
Primary Designation Director
Industry Life Sciences
First Appointment 30 Jul 2009

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director17 Aug 20092007₹151 Cr (FY 2025)Active
Primerose Vinimay Private Limited U51109WB2005PTC105670
Director30 Jul 20092005Converted To Llp

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Krish Biotech Research Private Limited
Primerose Vinimay Private Limited
Premium access

Shareholding and investment profile for Pooja Saraiya

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Pooja Saraiya

Pooja Saraiya was first appointed on 30 Jul 2009 as Director at Primerose Vinimay Private Limited.

Pooja Saraiya held 2 earlier board appointments: Krish Biotech Research Private Limited (Director, 17 Aug 2009 to 30 Jun 2014); Primerose Vinimay Private Limited (Director, 30 Jul 2009 to 20 Jun 2014).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available